克洛托 (Klotho) 可能具有的抗发作特性
Nasrin Ranjbar1, Mohammadreza Raeisi2, Mohammad Barzegar3
1Department of Clinical Biochemistry and Laboratory Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.
Brain research
|August 27, 2023
概括
克洛托 (Klotho) 是一种抗衰老蛋白,它有望保护大脑,并可能缓解发作. 对Klotho进行进一步的研究
科学领域:
- 神经科学是一个神经科学.
- 内分泌学 在内分泌学.
- 衰老研究研究 衰老研究
背景情况:
- 中反复发作可能会导致神经元逐渐损伤,并降低生活质量.
- 识别新的控制标志物和治疗策略至关重要.
- 克洛托 (Kl) 是一种抗衰老蛋白,具有与神经疾病相关的神经保护性.
研究的目的:
- 审查Klotho在中枢神经系统中的多方面的作用.
- 探索Klotho的潜在抗发作特性和机制.
- 突出Klotho作为管理的新治疗目标.
主要方法:
- 关于克洛托在中枢神经系统中的功能研究的文献综述.
- 对涉及Klotho神经保护性和潜在抗发作作用的拟议分子通路的分析.
- 关于Klotho与关键信号通路的相互作用的证据综合.
主要成果:
- 克洛托可以通过增强肌酸运输和激发性氨基酸载体来产生抗发作作用.
- 克洛托可能会抑制胰岛素/IGF-1,Wnt,TGF-β和RIG-I/NF-κB等途径.
- 克洛托可能会激活Nrf2和ASK1/p38 MAPK信号通路,从而促进神经保护.
结论:
- 克洛托显示出作为治疗发作缓解治疗剂的显著潜力.
- 了解克洛托在中枢神经系统中的复杂机制对于开发新的治疗方法至关重要.
- 本综述提供了Klotho抗性质的第一个全面概述.
相关概念视频
Antiepileptic Drugs: Potassium Channel Activators
210
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
210
Antihypertensive Drugs: Potassium-Sparing Diuretics
628
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
628
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
341
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
341
Antiepileptic Drugs: GABAergic Pathway Potentiators
453
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
453
Antiepileptic Drugs: Calcium Channel Blockers
446
Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
446
Antiepileptic Drugs: Glutamate Antagonists
418
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
418


